EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Economic evaluation of prenatal screening for fetal aneuploidies in Thailand

Preechaya Wongkrajang iD, Jiraphun Jittikoon, Wanvisa Udomsinprasert, Pattarawalai Talungchit iD, Sermsiri Sangroongruangsri, Saowalak Turongkaravee, Usa Chaikledkaew iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0291622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Preechaya Wongkrajang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Social, Economic and Administrative Pharmacy (SEAP) Graduate Program, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Prenatal Care, Down Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Systems Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Historically, there has been a lack of cost-effectiveness data regarding the inclusion of universal non-invasive prenatal testing (NIPT) for trisomy 21, 18, and 13 in the benefit package of the Universal Health Coverage (UHC) in Thailand. Therefore, this study aimed to perform the cost-benefit analysis of prenatal screening tests and calculate the budget impact that would result from the implementation of a universal NIPT program. A decision-tree model was employed to evaluate cost and benefit of different prenatal chromosomal abnormalities screenings: 1) first-trimester screening (FTS), 2) NIPT, and 3) definitive diagnostic (amniocentesis). The comparison was made between these screenings and no screening in three groups of pregnant women: all ages, < 35 years, and ≥ 35 years. The analysis was conducted from societal and governmental perspectives. The costs comprised direct medical, direct non-medical, and indirect costs, while the benefit was cost-avoidance associated with caring for children with trisomy and the loss of productivity for caregivers. Parameter uncertainties were evaluated through one-way and probabilistic sensitivity analyses. From a governmental perspective, all three methods were found to be cost-beneficial. Among them, FTS was identified as the most cost-beneficial, especially for pregnant women aged ≥ 35 years. From a societal perspective, the definitive diagnostic test was not cost-effective, but the other two screening tests were. The most sensitive parameters for FTS and NIPT strategies were the productivity loss of caregivers and the incidence of trisomy 21. Our study suggested that NIPT was the most cost-effective strategy in Thailand, if the cost was reduced to 47 USD. This evidence-based information can serve as a crucial resource for policymakers when making informed decisions regarding the allocation of resources for prenatal care in Thailand and similar context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal CareDown SyndromePregnancyChildFemaleHumansAdultCost-Benefit AnalysisThailandPrenatal DiagnosisAneuploidy

Autor:innen und Institutionen

  • Social, Economic and Administrative Pharmacy (SEAP) Graduate Program, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.
  • Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Preechaya Wongkrajang, Pattarawalai Talungchit, Usa Chaikledkaew

Förderung

  • Health Systems Research Institute

Zitieren

APA

Wongkrajang, P., Jittikoon, J., Udomsinprasert, W., Talungchit, P., Sangroongruangsri, S., Turongkaravee, S., & Chaikledkaew, U. (2023). Economic evaluation of prenatal screening for fetal aneuploidies in Thailand. PLOS ONE. https://doi.org/10.1371/journal.pone.0291622

Vancouver

Wongkrajang P, Jittikoon J, Udomsinprasert W, Talungchit P, Sangroongruangsri S, Turongkaravee S, et al. Economic evaluation of prenatal screening for fetal aneuploidies in Thailand. PLOS ONE. 2023. doi:10.1371/journal.pone.0291622

BibTeX
@article{Wongkrajang2023,
  author = {Wongkrajang, Preechaya and Jittikoon, Jiraphun and Udomsinprasert, Wanvisa and Talungchit, Pattarawalai and Sangroongruangsri, Sermsiri and Turongkaravee, Saowalak and Chaikledkaew, Usa},
  title = {Economic evaluation of prenatal screening for fetal aneuploidies in Thailand},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0291622}
}
Kostenlos starten →